Dr. Muhammad Faraz Anwar
Category:
April 4, 2023
| PERSONAL INFORMATION | ||
| Campus | Bahria University Health Sciences Karachi | |
| Department | Biochemistry | |
| Designation | Assistant Professor | |
| Name | Dr. Muhammad Faraz Anwar | |
| Email Address | mehr.bumdc@bahria.edu.pk | |
| Phone Office Ext | 021-35319491-9 (1054) | |
| Research Area | Computer aided Drug Discovery, Biomarker discovery, Bioinformatics, Molecular Biology. | |
| Number of Publications | 10 | |
| Qualification | |||
| Degree | Passing Year | Majors | University |
| PhD | 2018 | Biochemistry | University of Karachi |
| MSc | 2009 | Biochemistry | University of Karachi |
| BSc | 2006 | Chemistry, Biochemistry, Botany | University of Karachi |
| Teaching Experience | |||
| Designation | From | To | Organization |
| Assistant Professor | April 2021 | Till to date | Bahria University Health Sciences Karachi |
| Visiting faculty | Jan-2020 | March 2020 | University of Karachi |
| Visiting faculty | Jan-2020 | March 2020 | Iqra University |
| Visiting faculty | 2013 | 2014 | Baqai Institute of Information Technology |
| Publications | |||
| 1. | Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases. PLoS One. 2022 Dec 30;17(12):e0279270. doi: 10.1371/journal.pone.0279270. |
||
| 2. | Baseline MMP expression in periapical granuloma and its relationship with periapical wound healing after surgical endodontic treatment. BMC Oral Health. 2021 Nov 3; 21(1):562. doi: 10.1186/s12903-021-01904-6 | ||
| 3. | Evaluation of anti-EGFR potential of quinazoline derivatives using molecular docking: An in silico approach. Biotechnology and Applied Biochemistry 2021 May 24. doi: 10.1002/bab.2199 | ||
| 4. | An in silico approach to analyze HCV genotype-specific binding-site variation and its effect on drug–protein interaction. Scientific Reports 2020 Nov 30; 10(1):20885. doi: 10.1038/s41598-020-77720-9 | ||
| 5. | Application of an Integrated Cheminformatics-Molecular Docking Approach for Discovery for physiochemically similar analogs of Fluoroquinolones as Putative HCV Inhibitors. Computational Biology and Chemistry 2020 Feb; 84:107167. doi: 10.1016/j.compbiolchem.2019.107167 | ||
| 6. | Integrated Chemoinformatics-Molecular Docking Approach to Drug Discovery Against Viruses. Infectious Disorders Drug Targets. 2020;20(2):150-159. Epub 2018 Oct 19. doi: 10.2174/1871526518666181019162359 |
||
| 7. | Simian Virus 40 Large T Antigen as a Model to Test the Efficacy of Flouroquinolones against Viral Helicases. Bioinformation. 2018 Feb 28;14(2):75-79. doi: 10.6026/97320630014075 |
||
| 8. | Two for one: Viral helicases as an ideal target for HIV and HCV co-infection. Medical Hypotheses. 2018 Jul;116:139-140. doi: 10.1016/j.mehy.2018.05.004 |
||
| 9. | New anthrarobin acyl derivatives as butyrylcholinesterase inhibitors: synthesis, in vitro and in silico studies. Heliyon. 2017 Jul 10;3(7):e00350. doi: 10.1016/j.heliyon.2017.e00350 |
||
| 10. | Response to the editor regarding the article entitled “How Pakistan’s media spreads the message about reproductive and sexual health” published in BMJ. BMJ 2015;350:h1309 doi: http://dx.doi.org/10.1136/bmj.h1309. http://www.bmj.com/content/350/bmj.h1309/rr-3 |
||